<DOC>
	<DOCNO>NCT00892203</DOCNO>
	<brief_summary>This study ass efficacy safety BGG492 use treat migraine pain .</brief_summary>
	<brief_title>Efficacy Safety BGG492 Treatment Migraine</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>Diagnosis moderate severe migraine least 1 year At least 1 migraine episode , 15 migraine day per month Past use triptans Migraine onset 50 year age Diagnosis basilar , ophthalmoplegic hemiplegic migraine . More 6 nonmigraine headache per month Patients receive migraine prophylaxis treatment Patients receive regular treatment psychoactive drug Smokers Patients high low body weight Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Headache</keyword>
</DOC>